Anzeige
Mehr »
Login
Mittwoch, 02.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DFJP | ISIN: US65345B2016 | Ticker-Symbol:
NASDAQ
02.04.25
21:42 Uhr
2,020 US-Dollar
+0,140
+7,45 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXALIN TECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
NEXALIN TECHNOLOGY INC 5-Tage-Chart

Aktueller Chart NEXALIN TECHNOLOGY Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
NEXALIN TECHNOLOGY INC-Investoren interessieren sich auch für diese Wertpapiere
Pfizer: ABRYSVO Now Approved In The EU To Prevent RSV In Adults Aged 18 And OlderNEW YORK CITY (dpa-AFX) - Pfizer (PFE) announced the European Commission has issued a decision amending the marketing authorization for ABRYSVO, the company's bivalent respiratory syncytial...
► Artikel lesen
Pfizer Inc.: European Commission Approves Pfizer's RSV Vaccine ABRYSVO to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease ABRYSVO is the first and only RSV vaccine approved in the European Union (EU) for non-pregnant adults aged 18-49 Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has...
► Artikel lesen
Pfizer Aktie: Dauerhafte Unklarheiten?Bundesstaatsanwälte in Manhattan untersuchen Behauptungen über eine angeblich verzögerte Veröffentlichung von COVID-19-Impfstoffresultaten durch den Pharmariesen. Die Aktien des Pharmariesen Pfizer...
► Artikel lesen
Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 OutlookNEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and...
► Artikel lesen
Oscar Health Announces Results for Third Quarter 2024NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the third quarter ended...
► Artikel lesen
Innoviz Technologies: Innoviz Reports Fourth Quarter and Full Year 2024 ResultsRecent financial and business developments leave Innoviz well-prepared for multiple program SOPs in 2026 and volume production of LiDARs in 2027 Partnership announcements...
► Artikel lesen
Innoviz Technologies: Innoviz, in Collaboration with NVIDIA, Showcasing Cutting-Edge Perception Software with NVIDIA DRIVE AGX Orin at CES 2025, Unveiling New Software-Driven FeaturesInnoviz Perception Software offers key features running with the NVIDIA DRIVE AGX Orin platformInnoviz booth at CES is on West Hall, booth #4216 TEL AVIV, Israel, Jan. 7, 2025 /PRNewswire/...
► Artikel lesen
Innoviz Technologies: Innoviz Reports Third Quarter 2024 ResultsEntered two new OEM programs through agreement with Level 4 platform partner with expected SOP in 2026; Met operational target of 2-3 additional customer programs...
► Artikel lesen